KONDO Shunsuke 近藤俊輔

Researcher Number	90546201
Other IDs	https://orcid.org/0000-0001-9565-117X
Affiliation (based on the past Project Information) *help	2015: 国立研究開発法人国立がん研究センター, その他部局等, 研究員 2015: 国立研究開発法人国立がん研究センター, 中央病院, 医員 2014: 独立行政法人国立がん研究センター, 早期・探索臨床研究センター, 医員 2014: 国立がん研究センター中央病院, 肝胆膵内科, 医員 2012 – 2014: 独立行政法人国立がん研究センター, 中央病院, 医員
Review Section/Research Field	Principal Investigator Gastroenterology Except Principal Investigator Medical pharmacy
Keywords	Principal Investigator 分子標的治療薬 / 阻害剤 / 分子標的治療 / 融合遺伝子 / FGFR / 胆道がん Except Principal Investigator 抗がん剤 / 副作用

Is FGFR2 fusion real target for bile tract cancer patients?Principal Investigator
- Principal Investigator
  
  Shunsuke Kondo
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  National Cancer Center Japan
Reverse omics analysis for mechanisms on hand-foot syndrome and predictive system construction.
- Principal Investigator
  
  SAITO Yoshiro
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Medical pharmacy
- Research Institution
  National Institute of Health Sciences

All 2016 Other

All Journal Article Presentation

[Journal Article] Trends in the development of MET inhibitors for hepatocellular carcinoma.2016
- Author(s)
  Okuma HS, Kondo S.
- Journal Title
  
  Future Oncology
  
  Volume: 12 Issue: 10 Pages: 1275-1286
- DOI
  10.2217/fon.16.3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26860537
[Journal Article] C-Reactive Protein Level Is an Indicator of the Aggressiveness of Advanced Pancreatic Cancer.2016
- Author(s)
  Mitsunaga S, Ikeda M, Shimizu S, Ohno I, Takahashi H, Okuyama H, Ueno H, Morizane C, Kondo S, Sakamoto Y, Okusaka T, Ochiai A.
- Journal Title
  
  Pancreas
  
  Volume: 45 Issue: 1 Pages: 110-116
- DOI
  10.1097/mpa.0000000000000465
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26860537, KAKENHI-PROJECT-26460930
[Journal Article] Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.2016
- Author(s)
  Shoji H, Morizane C, Sakamoto Y, Kondo S, Ueno H, Takahashi H, Ohno I, Shimizu S, Mitsunaga S, Ikeda M, Okusaka T.
- Journal Title
  
  Japanese journal of clinical oncology
  
  Volume: 46 Pages: 132-137
- DOI
  10.1093/jjco/hyv179
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26860537, KAKENHI-PROJECT-16K19381
[Journal Article] Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients.2016
- Author(s)
  Shiba S, Morizane C, Hiraoka N, Sasaki M, Koga F, Sakamoto Y, Kondo S, Ueno H, Ikeda M, Yamada T, Shimada K, Kosuge T, Okusaka T.
- Journal Title
  
  Pancreatology
  
  Volume: 16 Issue: 1 Pages: 99-105
- DOI
  10.1016/j.pan.2015.11.001
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26860537
[Presentation] リピドミクス解析による手足症候群関連代謝物候補のin vitro 探索．
- Author(s)
  斎藤嘉朗，松澤由美子，嶽本和久，石川将己，齊藤公亮，細井寛子，近藤俊輔，上野秀樹，奥坂拓志，前川京子
- Organizer
  日本薬学会第135年会
- Place of Presentation
  神戸市
- Year and Date
  2015-03-26 – 2015-03-28
- Data Source
  KAKENHI-PROJECT-24659078

1. SAITO Yoshiro (50215571)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
2. MAEKAWA Keiko (70270626)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

KONDO Shunsuke 近藤 俊輔

Research Projects

Research Products

Co-Researchers

Is FGFR2 fusion real target for bile tract cancer patients?Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Reverse omics analysis for mechanisms on hand-foot syndrome and predictive system construction.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Trends in the development of MET inhibitors for hepatocellular carcinoma.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] C-Reactive Protein Level Is an Indicator of the Aggressiveness of Advanced Pancreatic Cancer.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients.2016

Author(s)

Journal Title

DOI

Data Source

[Presentation] リピドミクス解析による手足症候群関連代謝物候補のin vitro 探索．

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

KONDO Shunsuke 近藤俊輔